Recent Company News

• 12:37 AM ET Nov 06, 2025
  

  Alfresa Holdings reports H1 net income attributable ¥11.52B vs guidance ¥11.50B (¥2213.5000, +43.5)

• 07:33 PM ET Oct 30, 2025
  

  Alfresa Holdings guides H1 net income attributable ¥11.50B vs prior guidance ¥9.10B (¥2142.5000, 0)

• 02:55 AM ET Sep 19, 2025
  

  Japan approves manufacturing and sale of Alfresa's neffy 1mg and 2mg nasal sprays to suppress anaphylaxis (¥2185.5000, 0)

• 12:07 AM ET Sep 11, 2025
  

  Alfresa Holdings subsidiary Tohoku Alfresa to acquire East Japan Medical System; term undisclosed (¥2289.5000, +3)

• 01:07 AM ET Aug 06, 2025
  

  Alfresa Holdings reports Q1 net income attributable ¥5.00B vs FactSet ¥4.80B [1 est] (¥2246.0000, +41.5)

• 11:04 PM ET May 21, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (43 total)

• 11:01 PM ET May 15, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (48 total)

• 01:35 AM ET May 15, 2025
  

  Alfresa Holdings releases 2025-27 Management Plan (¥2006.0000, -119.5)

• 01:23 AM ET May 15, 2025
  

  Alfresa Holdings reports FY net income attributable ¥27.39B vs guidance ¥28.00B, FactSet ¥30.52B [3 est, ¥29.80-30.90B] (¥2020.5000, -105)

• 11:05 PM ET Apr 13, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day